Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI3 Energy Regulatory News (I3E)

  • This share is currently suspended. It was suspended at a price of 12.74
  • There is currently no data for I3E

Form 8.3 - I3E LN

18 Oct 2024 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

i3 Energy plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

17 October 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

Gran Tierra Energy, Inc.

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

0.01p ordinary

 

 

 

Interests

 

Short positions

 

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

18,870,876

 

1.57%

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

 

TOTAL:

 

18,870,876

 

1.57%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

 

Number of securities

 

Price per unit

0.01p ordinary

 

Purchase

 

500,000

 

12.78p

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

 

No

Date of disclosure:

 

18 October 2024

Contact name:

 

James Evans

Telephone number:

 

+44 203 161 0743

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241018635101/en/

Copyright Business Wire 2024

Date   Source Headline
28th Sep 202111:25 amRNSH1 2021 Earnings Webcast
27th Sep 20214:44 pmRNSPresentation
27th Sep 20217:00 amRNSInterim Report and Dividend Declaration
16th Sep 20217:00 amRNSNotice of Half Year 2021 Results and Webcast
15th Sep 20219:53 amRNSWarrant Exercise and Share Issuance
9th Sep 20217:00 amRNSOperational Update
2nd Sep 20213:59 pmRNSHolding(s) in Company
2nd Sep 20213:58 pmRNSHolding(s) in Company
23rd Aug 20217:00 amRNSClosing of Previously Announced Acquisition
16th Aug 20217:00 amRNSOperational and Financial Update
30th Jul 20216:16 pmRNSIssue of Share Options
29th Jul 20217:00 amRNSOperational Update
28th Jul 20214:58 pmRNSHolding(s) in Company
28th Jul 20214:57 pmRNSHolding(s) in Company
28th Jul 20214:55 pmRNSHolding(s) in Company
27th Jul 20213:05 pmRNSAdmission to Trading of Share Capital
26th Jul 202111:25 amRNSResult of General Meeting
15th Jul 20218:37 amRNSOperational Update
9th Jul 20214:38 pmRNSPosting of Shareholder Circular & Options Issuance
8th Jul 20217:01 amRNSNew Corporate Presentation
8th Jul 20217:00 amRNSDividend Declaration
7th Jul 20218:17 amRNSResults of Accelerated Bookbuild
7th Jul 20217:01 amRNSPrimaryBid Offer
7th Jul 20217:00 amRNSAlberta Acquisition and Proposed Placing
6th Jul 20214:40 pmRNSSecond Price Monitoring Extn
6th Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20217:00 amRNSOperational Update
1st Jul 20217:29 amRNSResult of AGM
30th Jun 20217:00 amRNSCapital Restructuring and Wapiti Acquisition
28th Jun 20217:00 amRNSOperational Update
17th Jun 20217:01 amRNSOperational & Dividend Update & Prod. Acquisition
17th Jun 20217:00 amRNSi3 Canada Ltd YE 2020 Reserves
3rd Jun 202111:53 amRNSResult of General Meeting
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20217:15 amRNSFinal Results for the year ended 31 December 2020
1st Jun 20217:00 amRNSSouth Simonette Consolidation – ROFR Exercise
18th May 20219:31 amRNSReduction of Capital
17th May 20217:00 amRNSContract Restructure & Dividend Creditor Consent
5th May 20217:00 amRNSOperational and Financial Update
29th Apr 20218:56 amRNSExercise of Options and Share Issuance
22nd Apr 20215:11 pmRNSHolding(s) in Company
16th Apr 20217:00 amRNSWarrant Exercise and Share Issuance
7th Apr 20213:49 pmRNSHolding(s) in Company
31st Mar 20217:00 amRNSOperational and Financial Update
23rd Mar 20213:15 pmRNSHolding(s) in Company
16th Mar 20213:17 pmRNSHolding(s) in Company
24th Feb 20219:05 amRNSSecond Price Monitoring Extn
24th Feb 20219:00 amRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.